MFS Emerging Markets Debt R4 (MEDGX)

Fund Assets	7.54B
Expense Ratio	0.82%
Min. Investment	$0.00
Turnover	69.00%
Dividend (ttm)	0.70
Dividend Yield	5.58%
Dividend Growth	0.18%
Payout Frequency	Monthly
Ex-Dividend Date	Aug 31, 2026

Previous Close	12.61
YTD Return	2.65%
1-Year Return	7.65%
5-Year Return	9.82%
52-Week Low	12.38
52-Week High	12.94
Beta (5Y)	n/a
Holdings	509
Inception Date	n/a

About MEDGX

MFS Emerging Markets Debt Fund R4 is an actively managed mutual fund focused on generating total return with an emphasis on high current income while also considering capital appreciation. The strategy concentrates on debt issued by governments, quasi-sovereigns, and corporations that are economically tied to emerging markets, primarily in Latin America, Eastern Europe, Asia, Africa, and the Middle East. The portfolio typically allocates at least 80% to emerging-markets debt and may utilize U.S. Treasuries and other liquid instruments to manage volatility and downside risk. The fund employs a research-intensive, country- and security-selection process led by a seasoned management team with long-standing continuity, and it benchmarks against JPMorgan’s Emerging Markets Bond Index Global. Class R4 shares are designed for eligible retirement and institutional platforms and feature no front-end or deferred sales charges, with a net expense ratio commonly cited around the R4 class level. The fund’s role in portfolios is to provide diversified exposure to hard-currency emerging-markets fixed income, balancing income generation with risk-managed participation in developing credit markets.

• Fund Family: MFS
• Category: Emerging Markets Bond
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: MEDGX
• Share Class: R4

Performance

MEDGX had a total return of 7.65% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.36%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
FGYMX	Fidelity	Fidelity Advisor New Markets Income C	1.79%
FGWMX	Fidelity	Fidelity Advisor New Markets Income M	1.04%
FGBMX	Fidelity	Fidelity Advisor New Markets Income Z	0.69%
FGZMX	Fidelity	Fidelity Advisor New Markets Income I	0.79%
FNMIX	Fidelity	Fidelity New Markets Income Fund	0.75%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
MEDHX	R6	0.71%
MEDIX	I	0.82%
MEDFX	R3	1.07%
MEDAX	A	1.07%

Dividend History

Ex-Dividend	Amount	Pay Date
Aug 31, 2026	$0.0622	Sep 1, 2026
Jul 31, 2026	$0.06219	Aug 3, 2026
Jun 30, 2026	$0.06019	Jul 1, 2026
May 29, 2026	$0.05773	Jun 1, 2026
Apr 30, 2026	$0.05768	May 1, 2026
Mar 31, 2026	$0.05768	Apr 1, 2026

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Sep 8, 2026

Data Sources Report a data error